Neogen Corp

Market Summary

USD18.18-0.17

Market Closed

-0.93%

NEOG Alerts

1 major insider buys recently.
Big jump in Revenue (Y/Y)
Big fall in earnings (Y/Y)

NEOG Stock Price

View Fullscreen

NEOG RSI Chart

NEOG Alerts

1 major insider buys recently.
Big jump in Revenue (Y/Y)
Big fall in earnings (Y/Y)

NEOG Valuation

Market Cap

3.9B

Price/Earnings (Trailing)

-147.97

Price/Sales (Trailing)

4.28

EV/EBITDA

29.57

Price/Free Cashflow

50.3

NEOG Price/Sales (Trailing)

NEOG Profitability

EBT Margin

-1.50%

Return on Equity

-0.43%

Return on Assets

-0.3%

Free Cashflow Yield

1.99%

NEOG Fundamentals

NEOG Revenue

Revenue (TTM)

919.1M

Revenue Y/Y

73.02%

Revenue Q/Q

-5.3%

NEOG Earnings

Earnings (TTM)

-26.6M

Earnings Y/Y

-71.15%

Earnings Q/Q

-73.03%

Price Action

Last 7 days

4.2%

Last 30 days

17.2%

Last 90 days

-6.8%

Trailing 12 Months

17.1%

How does NEOG drawdown profile look like?

NEOG Financial Health

Current Ratio

5.18

NEOG Investor Care

Shares Dilution (1Y)

100.59%

Diluted EPS (TTM)

-0.13

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	720.7M	822.4M	919.1M	0
2022	514.5M	527.2M	531.2M	630.7M
2021	450.1M	468.5M	487.4M	503.0M
2020	418.9M	418.2M	426.1M	433.3M
2019	412.5M	414.2M	416.0M	416.7M
2018	388.7M	397.9M	403.3M	409.7M
2017	352.8M	361.6M	372.2M	382.1M
2016	309.8M	321.3M	330.1M	341.2M
2015	271.7M	283.1M	290.3M	301.5M
2014	236.2M	247.4M	256.5M	265.3M
2013	200.1M	207.5M	216.3M	225.2M
2012	179.1M	184.0M	188.1M	193.9M
2011	164.6M	172.7M	175.5M	176.4M
2010	0	140.5M	148.6M	156.6M

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for NEOG

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 03, 2023	boehm william t	bought	32,110	16.055	2,000	-
Oct 25, 2023	jones douglas edward	bought	151,727	15.1727	10,000	chief operating officer
Oct 13, 2023	lilly jason warren	sold	-5,300	15.1	-351	vice president
Oct 12, 2023	tobin james p	bought	45,567	15.189	3,000	-
Oct 11, 2023	lilly jason warren	sold	-30,087	15.6949	-1,917	vice president
Oct 11, 2023	boehm william t	sold	-40,455	15.614	-2,591	-
Oct 11, 2023	naemura david h.	bought	150,333	15.0333	10,000	cfo
Aug 18, 2023	boehm william t	sold	-33,890	22.5939	-1,500	-
Aug 18, 2023	boehm william t	acquired	23,430	15.62	1,500	-
Apr 25, 2023	jones douglas edward	sold (taxes)	-4,950	16.67	-297	chief operating officer

Which funds bought or sold NEOG recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Dec 06, 2023	CITIGROUP INC	reduced	-3.69	-428,513	1,964,680	-%
Nov 30, 2023	Neo Ivy Capital Management	reduced	-72.96	-542,000	162,000	0.07%
Nov 27, 2023	BANQUE PICTET & CIE SA	unchanged	-	-7,793,080	45,010,500	0.53%
Nov 24, 2023	DEUTSCHE BANK AG\	added	19.45	35,920	2,011,520	-%
Nov 21, 2023	COMERICA BANK	added	917	12,356,800	12,451,800	0.06%
Nov 20, 2023	SILVER OAK SECURITIES, INCORPORATED	new	-	1,483	1,483	-%
Nov 17, 2023	SkyView Investment Advisors, LLC	unchanged	-	-22,000	130,000	0.05%
Nov 17, 2023	Diversified Trust Co	added	8.36	-41,823	505,863	0.02%
Nov 17, 2023	OLD NATIONAL BANCORP /IN/	reduced	-7.56	-63,822	237,219	0.01%
Nov 16, 2023	Creative Planning	added	0.38	-77,011	456,604	-%

Latest Funds Activity

Are funds buying NEOG calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NEOG

No. of Funds

Schedule 13G FIlings of Neogen Corp

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2023	susquehanna securities, llc	3.8%	8,291,607	SC 13G/A
Feb 14, 2023	norges bank	8.52%	18,422,570	SC 13G/A
Feb 09, 2023	vanguard group inc	8.82%	19,057,576	SC 13G/A
Feb 08, 2023	wasatch advisors inc	-	0	SC 13G/A
Jan 23, 2023	blackrock inc.	11.3%	24,460,988	SC 13G/A
Sep 16, 2022	susquehanna securities, llc	5.4%	11,733,386	SC 13G
Sep 09, 2022	wasatch advisors inc	-	0	SC 13G/A
Sep 01, 2022	norges bank	5.79%	6,248,066	SC 13G
Feb 14, 2022	brown capital management llc	11.04%	11,899,239	SC 13G/A
Feb 11, 2022	wasatch advisors inc	-	0	SC 13G

Recent SEC filings of Neogen Corp

View All Filings

Date Filed	Form Type	Document
Nov 03, 2023	4	Insider Trading
Oct 31, 2023	4	Insider Trading
Oct 31, 2023	4	Insider Trading
Oct 31, 2023	4	Insider Trading
Oct 31, 2023	4	Insider Trading
Oct 31, 2023	4	Insider Trading
Oct 31, 2023	4	Insider Trading
Oct 31, 2023	4	Insider Trading
Oct 31, 2023	4	Insider Trading
Oct 31, 2023	4	Insider Trading

Peers (Alternatives to Neogen Corp)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	160.7B	29.6B	10.51%	-19.98%	27.16	5.44	-5.39%	-12.54%
IDXX	44.1B	3.6B	24.23%	23.99%	53.65	12.3	7.43%	22.86%
A	37.3B	7.0B	16.28%	-18.61%	32.89	5.33	5.03%	-14.68%
DGX	15.2B	9.3B	1.84%	-9.68%	19.95	1.64	-9.69%	-38.22%
EXAS	11.7B	2.4B	2.99%	40.82%	-41.48	4.86	19.99%	60.62%
MID-CAP
CRL	10.5B	4.2B	16.20%	-2.67%	22.08	2.49	11.49%	8.84%
MEDP	8.7B	1.8B	2.84%	34.94%	31.81	4.88	29.62%	20.49%
NTRA	6.9B	988.7M	40.66%	50.03%	-13.86	7	27.41%	8.51%
NEOG	3.9B	919.1M	17.21%	17.06%	-147.97	4.28	73.02%	-172.93%
GH	3.0B	535.8M	8.75%	-45.64%	-7.02	5.66	24.38%	26.34%
SMALL-CAP
CDNA	531.2M	297.1M	54.98%	-22.82%	-5.87	1.79	-6.74%	-21.60%
ACRS	71.5M	21.4M	-81.47%	-93.49%	-0.62	3.34	-8.80%	-39.66%
AWH	31.2M	9.2M	-11.33%	-33.68%	-1.76	3.4	16.43%	48.38%
APDN	12.0M	13.4M	-4.35%	-39.31%	-1.21	0.9	-26.43%	-20.54%
BIOC	120.4K	-	-82.76%	-93.43%	0	0.76	-57.78%	-93.13%

Neogen Corp News

Latest updates

SETE News • 07 Dec 2023 • 06:40 pm • 34 hours ago

Neogen Corp. (NEOG) looking to reclaim success with recent ...

Yahoo Finance • 26 Oct 2023 • 07:00 am • 43 days ago

Insider Buying: Douglas Jones Acquires 10,000 Shares of Neogen ...

Yahoo Finance • 17 Oct 2023 • 07:00 am • 52 days ago

Top 20 Animal Health Companies in the World

Nasdaq • 10 Oct 2023 • 07:00 am • 59 days ago

Markets Today: Stocks Slightly Higher on Prospects of Additional ...

Yahoo Finance • 04 Sep 2023 • 07:00 am • 3 months ago

Why Natera Inc's Stock Skyrocketed 27% in a Quarter: A Deep Dive

GuruFocus.com • 30 Aug 2023 • 07:00 am • 3 months ago

Why Natera Inc's Stock Skyrocketed 21% in a Quarter: A Deep Dive

Seeking Alpha • 30 Aug 2022 • 07:00 am • 15 months ago

3M sets final exchange ratio in connection with Neogen transaction ...

Greater Wilmington Business Journal • 26 Jul 2022 • 07:00 am • 16 months ago

Father and son buy longtime Wilmington awning business

Spokane Journal of Business • 13 Jan 2022 • 08:00 am • 23 months ago

Paw Print Genetics acquired by Neogen

ThinkMarkets • 15 Jun 2021 • 04:37 pm • 2 years ago

Our Contract Specifications - Get Trading

TMS Brokers • 13 May 2021 • 04:04 pm • 2 years ago

Akcje Boeing Co: Aktualny kurs - Bezpieczny Dom Maklerski TMS ...

TMS Brokers • 16 Nov 2019 • 04:39 pm • 4 years ago

Euro Korona szewdzka - forex - Aktualny Kurs, Cena i Notowania ...

Thomasnet • 26 Mar 2019 • 07:00 am • 4 years ago

New Reveal 3-D and Veratox Kits for Testing of Coconut in Food ...

InvestorIdeas.com • 30 Aug 2018 • 06:22 pm • 5 years ago

Free stock directory of Luxury Brand Retail Stocks for investing ideas ...

InvestorIdeas.com • 30 Aug 2018 • 06:22 pm • 5 years ago

Free Food and Beverage stocks directory, wine stocks, bottled water ...

Financials for Neogen Corp

Income Statement (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	-5.3%	229	242	218	230	132	140	128	131	128	127	117	115	109	109	100	108	101	110	98.00	107	100
Gross Profit	-5.2%	117	123	108	113	62.00	65.00	57.00	61.00	60.00	58.00	54.00	53.00	50.00	52.00	45.00	51.00	48.00	51.00	45.00	50.00	47.00
Operating Expenses	-2.1%	98.00	100	92.00	120	56.00	47.00	51.00	48.00	38.00	37.00	38.00	34.00	31.00	32.00	32.00	33.00	32.00	32.00	30.00	32.00	30.00
S&GA Expenses	6.7%	46.00	43.00	39.00	36.00	23.00	21.00	21.00	21.00	21.00	21.00	19.00	18.00	17.00	16.00	18.00	18.00	18.00	18.00	17.00	18.00	17.00
R&D Expenses	-4.7%	7.00	7.00	7.00	7.00	5.00	4.00	5.00	4.00	4.00	4.00	4.00	4.00	4.00	3.00	4.00	4.00	4.00	4.00	3.00	3.00	3.00
EBITDA Margin	-	-	-	0.08*	0.07*	0.13*	0.16*	0.17*	0.19*	0.20*	0.21*	0.21*	0.22*	0.22*	0.22*	0.21*	0.22*	0.22*	0.22*	0.22*	0.22*	0.23*
Income Taxes	-92.5%	0.00	2.00	-10.50	8.00	1.00	4.00	1.00	2.00	5.00	4.00	3.00	3.00	4.00	5.00	2.00	3.00	3.00	4.00	4.00	4.00	2.00
Earnings Before Taxes	-78.3%	2.00	8.00	-2.26	-34.09	7.00	19.00	7.00	13.00	22.00	20.00	16.00	19.00	20.00	21.00	14.00	19.00	18.00	19.00	17.00	20.00	17.00
EBT Margin	-	-	-	-0.01*	0.00*	0.08*	0.11*	0.12*	0.14*	0.16*	0.16*	0.17*	0.17*	0.17*	0.17*	0.17*	0.18*	0.18*	0.18*	0.18*	0.18*	0.18*
Net Income	-73.0%	2.00	6.00	8.00	-41.84	5.00	15.00	5.00	11.00	17.00	16.00	13.00	16.00	16.00	16.00	12.00	16.00	15.00	16.00	13.00	16.00	15.00
Net Income Margin	-	-	-	-0.02*	-0.03*	0.07*	0.09*	0.10*	0.11*	0.13*	0.13*	0.14*	0.14*	0.14*	0.14*	0.14*	0.14*	0.14*	0.15*	0.15*	0.16*	0.17*
Free Cashflow	-	-	-	-17.07	-18.73	-14.14	20.00	7.00	18.00	23.00	22.00	12.00	22.00	25.00	26.00	20.00	17.00	24.00	21.00	10.00	17.00	16.00

Balance Sheet
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	0.1%	4,561	4,554	4,561	4,563	977	993	981	968	932	920	880	846	822	797	774	751	721	696	673	660	641
Current Assets	-0.4%	584	586	555	643	608	627	610	611	609	591	555	578	557	537	515	500	474	450	423	414	396
Cash Equivalents	9.6%	179	163	67.00	100	107	44.00	43.00	51.00	71.00	76.00	73.00	114	61.00	66.00	51.00	66.00	56.00	42.00	94.00	102	97.00
Inventory	5.1%	141	134	144	136	129	122	113	107	102	101	99.00	93.00	98.00	95.00	89.00	86.00	88.00	86.00	85.00	79.00	79.00
Net PPE	11.2%	221	199	165	148	121	111	105	101	100	100	98.00	84.00	81.00	79.00	78.00	77.00	75.00	75.00	76.00	74.00	73.00
Goodwill	0.0%	2,138	2,137	2,135	2,122	1,975	143	150	143	130	131	133	112	112	110	110	104	103	104	104	103	103
Liabilities	-0.4%	1,415	1,420	1,383	1,457	94.00	106	106	101	77.00	80.00	73.00	68.00	70.00	72.00	62.00	60.00	61.00	58.00	53.00	58.00	59.00
Current Liabilities	-5.0%	138	145	107	153	67.00	78.00	66.00	63.00	51.00	54.00	46.00	45.00	46.00	48.00	39.00	39.00	40.00	38.00	34.00	39.00	39.00
LT Debt, Non Current	0.1%	886	885	885	924	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	0.4%	3,146	3,134	3,126	3,106	884	887	876	865	855	840	808	777	752	725	712	691	660	638	620	602	582
Retained Earnings	0.3%	567	565	559	551	593	588	573	568	557	540	524	510	495	479	462	450	434	419	403	390	374
Additional Paid-In Capital	0.1%	2,572	2,568	2,565	2,561	313	310	308	305	298	295	290	273	264	249	255	244	232	222	217	216	212
Accumulated Depreciation	-100.0%	-	120	-	-	-	105	-	-	-	98.00	-	-	-	75.00	-	-	-	66.00	-	-	-
Shares Outstanding	0.0%	216	216	216	216	108	108	108	108	107	107	107	106	106	106	106	105	105	104	104	104	104

Cashflow (Last 12 Months)
(In Millions)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	-74.7%	23,009	90,966	-17,069	-18,726	-14,143	20,390	6,591	17,847	23,210	21,969	11,596	22,390	25,134	25,628	19,778	16,753	23,719	20,877	10,382	16,501	16,082
Share Based Compensation	-8.0%	2,638	2,866	2,812	2,632	1,867	2,109	1,607	1,748	1,690	1,664	1,581	1,511	1,681	1,673	1,640	1,612	1,543	1,406	1,306	1,400	1,431
Cashflow From Investing	-226.3%	-8,684	6,876	19,523	93,002	81,638	-17,099	-15,386	-39,337	-25,407	-31,710	-60,918	22,796	-35,732	-12,208	-42,951	-18,265	-15,361	-75,515	-20,361	-15,698	-7,574
Cashflow From Financing	321.4%	1,062	252	-39,977	-79,261	905	-1,029	1,223	5,571	1,048	10,743	10,143	7,563	5,095	1,490	8,702	10,505	8,708	3,282	349	1,276	8,992

NEOG Income Statement

2023-08-31

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2023	Aug. 31, 2022
Revenues
Total revenue	$ 228,987	$ 132,349
Cost of Revenues
Total Cost of Revenues	112,226	70,079
Gross Profit	116,761	62,270
Operating Expenses
Sales and marketing	45,783	23,383
General and administrative	45,121	27,944
Research and development	6,722	4,881
Total Operating Expenses	97,626	56,208
Operating Income	19,135	6,062
Other (Expense) Income
Interest income	1,790	971
Interest expense	(18,456)	(2)
Other expense	(806)	(372)
Total Other (Expense) Income	(17,472)	597
Income Before Taxes	1,663	6,659
Provision for Income Taxes	160	1,450
Net Income	$ 1,503	$ 5,209
Net Income Per Share
Basic	$ 0.01	$ 0.05
Diluted	$ 0.01	$ 0.05
Weighted Average Shares Outstanding
Basic	216,309,084	107,837,295
Diluted	216,846,106	107,857,477
Product Revenues
Revenues
Total revenue	$ 204,401	$ 106,792
Cost of Revenues
Total Cost of Revenues	96,959	55,441
Service Revenues
Revenues
Total revenue	24,586	25,557
Cost of Revenues
Total Cost of Revenues	$ 15,267	$ 14,638

NEOG Balance Sheet

2023-08-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Aug. 31, 2023	May 31, 2023
Current Assets
Cash and cash equivalents	$ 178,832	$ 163,240
Marketable securities	60,424	82,329
Accounts receivable, net of allowance of $3,205 and $2,827	137,669	153,253
Inventories, net	140,692	133,812
Prepaid expenses and other current assets	66,176	53,297
Total Current Assets	583,793	585,931
Net Property and Equipment	221,090	198,749
Other Assets
Right of use assets	14,505	11,933
Goodwill	2,137,602	2,137,496
Intangible assets, net	1,588,066	1,605,103
Other non-current assets	16,049	15,220
Total Assets	4,561,105	4,554,432
Current Liabilities
Current portion of finance lease	2,642
Accounts payable	90,210	76,669
Accrued compensation	14,863	25,153
Income tax payable	5,399	6,951
Accrued interest	3,438	11,149
Deferred revenue	3,789	4,616
Other accruals	17,789	20,934
Total Current Liabilities	138,130	145,472
Deferred Income Tax Liability	354,792	353,427
Non-current debt	886,177	885,439
Other non-current liabilities	35,831	35,877
Total Liabilities	1,414,930	1,420,215
Commitments and Contingencies (note 12)
Equity
Preferred stock, $1.00 par value, 100,000 shares authorized, none issued and outstanding	0	0
Common stock, $0.16 par value, 315,000,000 shares authorized, 216,310,582 and 216,245,501 shares issued and outstanding at August 31, 2023 and May 31, 2023, respectively	34,610	34,599
Additional paid-in capital	2,571,517	2,567,828
Accumulated other comprehensive loss	(26,496)	(33,251)
Retained earnings	566,544	565,041
Total Stockholders' Equity	3,146,175	3,134,217
Total Liabilities and Stockholders' Equity	$ 4,561,105	$ 4,554,432

About Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

CEO	Mr. John Edward Adent
WEBSITE	www.neogen.com
EMPLOYEES	2640

Neogen Corp Frequently Asked Questions

What is the ticker symbol for Neogen Corp? What does NEOG stand for in stocks?

NEOG is the stock ticker symbol of Neogen Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Neogen Corp (NEOG)?

As of Fri Dec 08 2023, market cap of Neogen Corp is 3.93 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NEOG stock?

You can check NEOG's fair value in chart. The fair value of Neogen Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Neogen Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NEOG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Neogen Corp a good stock to buy?

The fair value guage provides a quick view whether NEOG is over valued or under valued. Whether Neogen Corp is cheap or expensive depends on the assumptions which impact Neogen Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NEOG.

What is Neogen Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 08 2023, NEOG's PE ratio (Price to Earnings) is -147.97 and Price to Sales (PS) ratio is 4.28. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NEOG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Neogen Corp's stock?

In the past 10 years, Neogen Corp has provided -0.004 (multiply by 100 for percentage) rate of return.

Market Summary

NEOG Alerts

NEOG Stock Price

NEOG RSI Chart

NEOG Alerts

NEOG Valuation

NEOG Price/Sales (Trailing)

NEOG Profitability

NEOG Fundamentals

NEOG Revenue

NEOG Earnings

Price Action

How does NEOG drawdown profile look like?

NEOG Financial Health

NEOG Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for NEOG

Which funds bought or sold NEOG recently?

Latest Funds Activity

Schedule 13G FIlings of Neogen Corp

Recent SEC filings of Neogen Corp

Peers (Alternatives to Neogen Corp)

Neogen Corp News

Financials for Neogen Corp

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Millions)

NEOG Income Statement

NEOG Balance Sheet

About Neogen Corp

Neogen Corp Frequently Asked Questions

What is the ticker symbol for Neogen Corp? What does NEOG stand for in stocks?

What is the market capital of Neogen Corp (NEOG)?

What is the fair value of NEOG stock?

Is Neogen Corp a good stock to buy?

What is Neogen Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

What is 5 year return on Neogen Corp's stock?

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)